Cite
HARVARD Citation
Alemao, E. et al. (n.d.). THU0341 Cost Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naïve RA Adult Patients by Anti-Cyclic Citrullinated Peptide-Positive Subgroups. Annals of the rheumatic diseases. p. 319. [Online].